Novo, Hims & Hers said to be eyeing a partnership to sell obesity drugs
Source: SeekingAlpha
2026-03-07 08:19:03 ET
More on Hims & Hers Health, Novo Nordisk
- CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
- Hims & Hers Health: Leaving GLP-1s Behind
- Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk
- Most and least shorted mid-to mega-cap healthcare stocks in February
- Hims & Hers back in red as FDA doubles down on GLP-1 compounders
Read the full article on Seeking Alpha
For further details see:
Novo, Hims & Hers said to be eyeing a partnership to sell obesity drugs
Novo Nordisk - Class B
NASDAQ: NONOF
NONOF Trading
-0.45% G/L:
$38.58 Last:
277 Volume:
$39.7699 Open:
NONOF Latest News
NONOF Stock Data
$217,715,792,624
1,607,906,287
N/A
1546
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
